EP 3325471 A1 20180530 - COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS
Title (en)
COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS
Title (de)
KOLONIESTIMULIERENDE FAKTOR-1-REZEPTOR(CSF-1R)-INHIBITOREN
Title (fr)
INHIBITEURS DU RÉCEPTEUR DE FACTEUR-1 DE STIMULATION DE COLONIES (CSF-1R)
Publication
Application
Priority
- US 201562194619 P 20150720
- US 2016042917 W 20160719
Abstract (en)
[origin: WO2017015267A1] Compounds of the formulas I and XIII, which are useful as colony stimulating factor-1 receptor inhibitors ("CSF 1R inhibitors").
IPC 8 full level
C07D 405/04 (2006.01); C07D 405/06 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); C07D 519/00 (2006.01)
CPC (source: EP IL KR RU US)
A61K 31/4184 (2013.01 - RU); A61K 31/437 (2013.01 - KR RU); A61K 31/4523 (2013.01 - RU); A61K 31/506 (2013.01 - RU); A61K 31/5377 (2013.01 - RU); A61P 19/02 (2018.01 - RU); A61P 25/00 (2018.01 - KR); A61P 25/28 (2018.01 - RU); A61P 35/00 (2018.01 - RU); A61P 37/06 (2018.01 - EP IL US); C07D 405/04 (2013.01 - EP IL KR RU); C07D 405/06 (2013.01 - EP IL RU US); C07D 471/04 (2013.01 - EP IL KR RU US); C07D 487/04 (2013.01 - EP IL KR RU US); C07D 519/00 (2013.01 - EP IL RU US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2017015267 A1 20170126; AR 105392 A1 20170927; AU 2016297558 A1 20180308; AU 2016297558 B2 20210325; AU 2021204116 A1 20210715; AU 2021204116 B2 20221201; AU 2023201013 A1 20230323; BR 112018001017 A2 20180918; BR 112018001017 B1 20240215; CA 2993018 A1 20170126; CA 3217238 A1 20170126; CL 2018000140 A1 20180817; CN 107922396 A 20180417; CN 107922396 B 20220805; CO 2018001621 A2 20180228; CR 20180109 A 20180503; DO P2018000008 A 20180515; EC SP18012103 A 20180430; EP 3325471 A1 20180530; GT 201800020 A 20191021; IL 256964 A 20180329; IL 256964 B 20211031; IL 276292 A 20200930; IL 276292 B1 20231001; IL 276292 B2 20240201; IL 305843 A 20231101; JP 2018524381 A 20180830; JP 2021107414 A 20210729; JP 2024028845 A 20240305; JP 6898914 B2 20210707; JP 7401482 B2 20231219; KR 102665765 B1 20240510; KR 20180030199 A 20180321; MA 42023 B2 20220131; MX 2018000880 A 20180824; MX 2021015102 A 20220221; MY 186368 A 20210716; NZ 739951 A 20240223; PE 20180573 A1 20180404; PH 12018500140 A1 20180723; RU 2018106060 A 20190820; RU 2018106060 A3 20191213; RU 2748884 C2 20210601; SG 10201912699R A 20200227; TN 2018000020 A1 20190708; TW 201716393 A 20170516; TW I734693 B 20210801; US 11274108 B2 20220315; US 2019016707 A1 20190117; US 2022396588 A1 20221215; US 2024217991 A1 20240704; ZA 201800082 B 20181219
DOCDB simple family (application)
US 2016042917 W 20160719; AR P160102184 A 20160719; AU 2016297558 A 20160719; AU 2021204116 A 20210618; AU 2023201013 A 20230221; BR 112018001017 A 20160719; CA 2993018 A 20160719; CA 3217238 A 20160719; CL 2018000140 A 20180117; CN 201680042348 A 20160719; CO 2018001621 A 20180220; CR 20180109 A 20160719; DO 2018000008 A 20180109; EC PI201812103 A 20180219; EP 16744651 A 20160719; GT 201800020 A 20180115; IL 25696418 A 20180117; IL 27629220 A 20200726; IL 30584323 A 20230911; JP 2018502627 A 20160719; JP 2021067423 A 20210413; JP 2023205068 A 20231205; KR 20187004799 A 20160719; MA 42023 A 20160719; MX 2018000880 A 20160719; MX 2021015102 A 20180119; MY PI2017705168 A 20160719; NZ 73995116 A 20160719; PE 2018000091 A 20160719; PH 12018500140 A 20180117; RU 2018106060 A 20160719; SG 10201912699R A 20160719; TN 2018000020 A 20160719; TW 105122945 A 20160720; US 201615745223 A 20160719; US 202217668209 A 20220209; US 202418404409 A 20240104; ZA 201800082 A 20180105